BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28831923)

  • 1. The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis.
    Blum K; Thanos PK; Wang GJ; Febo M; Demetrovics Z; Modestino EJ; Braverman ER; Baron D; Badgaiyan RD; Gold MS
    Curr Pharm Des; 2018 Feb; 23(39):6050-6061. PubMed ID: 28831923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine genetic risk is related to food addiction and body mass through reduced reward-related ventral striatum activity.
    Romer AL; Su Kang M; Nikolova YS; Gearhardt AN; Hariri AR
    Appetite; 2019 Feb; 133():24-31. PubMed ID: 30296504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity.
    Blum K; Febo M; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Demetrovics Z
    Curr Pharm Des; 2016; 22(38):5837-5854. PubMed ID: 27510492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
    Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
    Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Early Overfeeding on Palatable Food Preference and Brain Dopaminergic Reward System at Adulthood: Role of Calcium Supplementation.
    Conceição EP; Carvalho JC; Manhães AC; Guarda DS; Figueiredo MS; Quitete FT; Oliveira E; Moura EG; Lisboa PC
    J Neuroendocrinol; 2016 May; 28(5):. PubMed ID: 26929129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and glucose, obesity, and reward deficiency syndrome.
    Blum K; Thanos PK; Gold MS
    Front Psychol; 2014; 5():919. PubMed ID: 25278909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems.
    Gold MS; Blum K; Febo M; Baron D; Modestino EJ; Elman I; Badgaiyan RD
    Front Biosci (Schol Ed); 2018 Mar; 10(2):309-325. PubMed ID: 29293435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming reward deficiency syndrome by the induction of "dopamine homeostasis" instead of opioids for addiction: illusion or reality?
    Blum K; Soni D; Badgaiyan RD; Baron D
    J Osteopath Med; 2022 Apr; 122(7):333-337. PubMed ID: 35411759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food and drug reward: overlapping circuits in human obesity and addiction.
    Volkow ND; Wang GJ; Fowler JS; Tomasi D; Baler R
    Curr Top Behav Neurosci; 2012; 11():1-24. PubMed ID: 22016109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate intensity treadmill exercise alters food preference via dopaminergic plasticity of ventral tegmental area-nucleus accumbens in obese mice.
    Chen W; Wang HJ; Shang NN; Liu J; Li J; Tang DH; Li Q
    Neurosci Lett; 2017 Feb; 641():56-61. PubMed ID: 28130186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).
    Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mangucci JF; Braverman ER; Arcuri V; Deutsch R; Pons MM
    Med Hypotheses; 2007; 68(4):844-52. PubMed ID: 17071010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional epigenetics with a focus on amino acids: implications for the development and treatment of metabolic syndrome.
    Ji Y; Wu Z; Dai Z; Sun K; Wang J; Wu G
    J Nutr Biochem; 2016 Jan; 27():1-8. PubMed ID: 26427799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cue-induced firing of ventral tegmental area dopamine neurons by leptin and ghrelin.
    van der Plasse G; van Zessen R; Luijendijk MC; Erkan H; Stuber GD; Ramakers GM; Adan RA
    Int J Obes (Lond); 2015 Dec; 39(12):1742-9. PubMed ID: 26183405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-induced obesity causes ghrelin resistance in reward processing tasks.
    Lockie SH; Dinan T; Lawrence AJ; Spencer SJ; Andrews ZB
    Psychoneuroendocrinology; 2015 Dec; 62():114-20. PubMed ID: 26292268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.
    Blum K; Febo M; McLaughlin T; Cronjé FJ; Han D; Gold SM
    J Behav Addict; 2014 Sep; 3(3):149-56. PubMed ID: 25317338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Gilley ED; Bowirrat A; Gupta A; Giordano J; A Dennen C; R Braverman E; D Badgaiyan R; McLaughlin T; Baron D; Blum K
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37102488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
    Gold MS; Badgaiyan RD; Blum K
    Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.